Severity: Warning
Message: fopen(/var/lib/php/sessions/ci_sessionkuvhm9afcg386fhn12ia2fm0lrmti6fp): Failed to open stream: No space left on device
Filename: drivers/Session_files_driver.php
Line Number: 177
Backtrace:
File: /var/www/html/index.php
Line: 316
Function: require_once
Severity: Warning
Message: session_start(): Failed to read session data: user (path: /var/lib/php/sessions)
Filename: Session/Session.php
Line Number: 137
Backtrace:
File: /var/www/html/index.php
Line: 316
Function: require_once
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6716195 | PMC |
http://dx.doi.org/10.1021/acscentsci.9b00675 | DOI Listing |
Psychedelic Med (New Rochelle)
March 2024
Department of Psychiatry and Behavioral Sciences, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
Background: The Mystical Experience Questionnaire (MEQ-30) and Challenging Effects Questionnaire (CEQ) are two of the most widely used, validated instruments to probe subjective effects of psychedelic drugs. However, these assessments are lengthy and can be a burden to study participants or patients if administered during acute psychedelic effects, after resolution of psychedelic effects when participants are often fatigued, or in studies with multiple other assessments. The development of briefer measures can advance research and patient assessment.
View Article and Find Full Text PDFPsychedelic Med (New Rochelle)
June 2024
Department of Behavioral Health, Denver Health & Hospital Authority, Denver, Colorado, USA.
Introduction: Alcohol use disorder (AUD) is widespread and problematic in the United States, and current pharmacotherapy options have relatively modest effects. Therefore, novel interventions such as ketamine therapy have gained interest as potentially efficacious options, known to generate unique psychotherapeutic experiences. The present secondary analysis examines the acute subjective experiences-both quantitatively and qualitatively-of clinical trial participants with AUD who received intravenous (IV) ketamine therapy in the hospital setting.
View Article and Find Full Text PDFSmall
March 2025
State Key Laboratory of Separation Membranes and Membrane Process, School of Materials Science and Engineering, Tiangong University, Tianjin, 300387, P. R. China.
Precise separation of small organic molecules and electrolyte salts is critical for various industrial processes, necessitating advanced membranes with uniform pores. Proteins, as one typical nature polymer having the exactly same structure and molecular weight, offer a promising material for making such membranes. Here, hemoglobin (BHb) and lysozyme (Lyz) are utilized to fabricate precise nanofiltration membranes through amyloid-like co-assembly, triggered by Tris(2-carboxyethyl) phosphine.
View Article and Find Full Text PDFTarget Oncol
January 2025
College of Medicine and Public Health, Flinders University, Adelaide, SA, Australia.
Background: Tumour mutational burden (TMB) is an established biomarker for patients treated with immune checkpoint inhibitors (ICIs). The optimal TMB cut-off is uncertain. It is also uncertain whether there is a sharp TMB threshold or a more graduated change in clinical outcomes as TMB increases.
View Article and Find Full Text PDFPLoS One
December 2024
Center for Psychedelic and Consciousness Research, Department of Psychiatry and Behavioral Sciences, Johns Hopkins School of Medicine, Baltimore, MD, United States of America.
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!